Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (41)

2024

  1. Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?

    Parkinsonism and Related Disorders, Vol. 122

  2. DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease

    Annals of Clinical and Translational Neurology, Vol. 11, Núm. 8, pp. 2222-2229

  3. Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays

    PLoS Pathogens, Vol. 20, Núm. 9

  4. Fluid and tissue biomarkers in Parkinson's disease: Immunodetection or seed amplification? Central or peripheral?

    Parkinsonism and Related Disorders, Vol. 121

2023

  1. Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure

    Frontiers in Aging Neuroscience, Vol. 15

  2. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study

    European Radiology, Vol. 33, Núm. 7, pp. 4540-4551

2022

  1. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again

    Parkinsonism and Related Disorders, Vol. 99, pp. 33-41

  2. Differential Phospho-Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease

    Movement Disorders, Vol. 37, Núm. 5, pp. 1004-1015

  3. Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation Carriers

    Annals of Neurology, Vol. 92, Núm. 5, pp. 888-894

2021

  1. Exome-wide rare variant analysis in familial essential tremor

    Parkinsonism and Related Disorders, Vol. 82, pp. 109-116

  2. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  3. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Peripheral insulin and amylin levels in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 79, pp. 91-96

  2. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

  3. Transcriptomic differences in MSA clinical variants

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    npj Parkinson's Disease, Vol. 5, Núm. 1

  2. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  3. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

2017

  1. Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease

    Journal of the Neurological Sciences, Vol. 373, pp. 223-229

  2. Cross-sectional and longitudinal cognitive correlates of FDDNP PET and CSF amyloid-β and tau in Parkinson's disease

    Journal of Alzheimer's Disease, Vol. 55, Núm. 3, pp. 1261-1272